These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5111999)

  • 21. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.
    Pertwee RG
    Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of orally administered delta-9-tetrahydrocannabinol in man.
    Hosko MJ; Kochar MS; Wang RI
    Clin Pharmacol Ther; 1973; 14(3):344-52. PubMed ID: 4698562
    [No Abstract]   [Full Text] [Related]  

  • 23. Increase of serum prolactin in male rats by (minus)-trans-delta9-tetrahydrocannabinol.
    Daley JD; Branda LA; Rosenfeld J; Younglai EV
    J Endocrinol; 1974 Nov; 63(2):415-6. PubMed ID: 4443705
    [No Abstract]   [Full Text] [Related]  

  • 24. Acquisition and extinction of variable interval schedule behavior by rats under delta9-tetrahydrocannabinol.
    Ferraro DP; Gluck JP; Herndon GB
    Pharmacol Biochem Behav; 1974; 2(4):487-91. PubMed ID: 4421520
    [No Abstract]   [Full Text] [Related]  

  • 25. Dimethylheptyl-delta 6a-10a-tetrahydrocannabinol: effects after parenteral administration to man.
    Sidell FB; Pless JE; Neitlich H; Sussman P; Copelan HW; Sim VM
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):867-73. PubMed ID: 4571010
    [No Abstract]   [Full Text] [Related]  

  • 26. Analgesic activity of 9 -tetrahydrocannabinol in the rat and mouse.
    Buxbaum DM
    Psychopharmacologia; 1972; 25(3):275-80. PubMed ID: 5044401
    [No Abstract]   [Full Text] [Related]  

  • 27. Cannabis and alcohol: effects on stimulated car driving.
    Rafaelsen OJ; Bech P; Christiansen J; Christrup H; Nyboe J; Rafaelsen L
    Science; 1973 Mar; 179(4076):920-3. PubMed ID: 4569248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential neurochemistry and temporal pattern in rats treated orally with delta9-tetrahydrocannabinol for periods up to six months.
    Luthra UL; Rosenkrantz H; Heyman IA; Braude MC
    Toxicol Appl Pharmacol; 1975 May; 32(2):418-31. PubMed ID: 1171540
    [No Abstract]   [Full Text] [Related]  

  • 29. Lack of tolerance to 9 -tetrahydrocannabinol in chimpanzees.
    Ferraro DP; Grilly DM
    Science; 1973 Feb; 179(4072):490-2. PubMed ID: 4705343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cannabinoids given orally and reduced appetite on the male rat reproductive system.
    Fujimoto GI; Morrill GA; O'Connell ME; Kostellow AB; Retura G
    Pharmacology; 1982; 24(5):303-13. PubMed ID: 6285392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depth perception in rats following acute or chronic injections of D1- 9 tetrahydrocannabinol.
    Fried PA; Husband CA
    Life Sci I; 1973 Apr; 12(7):289-95. PubMed ID: 4695123
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of 1(2) -tetrahydrocannabinol on copulation in the male rat.
    Merari A; Barak A; Plaves M
    Psychopharmacologia; 1973; 28(3):243-6. PubMed ID: 4690999
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacologic effects and physiologic disposition of delta 6a,10a dimethyl heptyl tetrahydrocannabinol (DMHP) in man.
    Lemberger L; McMahon R; Archer R; Matsumoto K; Rowe H
    Clin Pharmacol Ther; 1974 Apr; 15(4):380-6. PubMed ID: 4821441
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative studies in man and in laboratory animals on 8 - and 9 -trans-tetrahydrocannabinol.
    Karniol IG; Carlini EA
    Pharmacology; 1973; 9(2):115-26. PubMed ID: 4713005
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of (-)-delta9-tetrahydrocannabinol on reserpine-induced hypothermia in rats.
    Englert LF; Ho BT; Taylor D
    Br J Pharmacol; 1973 Oct; 49(2):243-52. PubMed ID: 4793331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study.
    de Vries M; van Rijckevorsel DCM; Vissers KCP; Wilder-Smith OHG; van Goor H;
    Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1079-1086.e4. PubMed ID: 27720917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of synthetic 9 -tetrahydrocannabinol on pregnancy and offspring in the rat.
    Borgen LA; Davis WM; Pace HB
    Toxicol Appl Pharmacol; 1971 Dec; 20(4):480-6. PubMed ID: 5143590
    [No Abstract]   [Full Text] [Related]  

  • 38. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part II: comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents.
    Manwell LA; Ford B; Matthews BA; Heipel H; Mallet PE
    J Pharmacol Toxicol Methods; 2014; 70(1):112-9. PubMed ID: 24956154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of delta9-THC on food and water intake of deprivation experienced rats.
    Gluck JP; Ferraro DP
    Behav Biol; 1974 Jul; 11(3):395-401. PubMed ID: 4413126
    [No Abstract]   [Full Text] [Related]  

  • 40. Delta-8- and delta-9-tetrahydrocannabinol comparison in man by oral and intravenous administration.
    Hollister LE; Gillespie HK
    Clin Pharmacol Ther; 1973; 14(3):353-7. PubMed ID: 4698563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.